Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells. 2011

Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, University Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia.

Liver cancer has become one of the major types of cancer with high mortality and liver cancer is not responsive to the current cytotoxic agents used in chemotherapy. The purpose of this study was to examine the in vitro cytotoxicity of goniothalamin on human hepatoblastoma HepG2 cells and normal liver Chang cells. The cytotoxicity of goniothalamin against HepG2 and liver Chang cell was tested using MTT cell viability assay, LDH leakage assay, cell cycle flow cytometry PI analysis, BrdU proliferation ELISA assay and trypan blue dye exclusion assay. Goniothalamin selectively inhibited HepG2 cells [IC₅₀ = 4.6 (±0.23) µM in the MTT assay; IC₅₀ = 5.20 (±0.01) µM for LDH assay at 72 hours], with less sensitivity in Chang cells [IC₅₀ = 35.0 (±0.09) µM for MTT assay; IC₅₀ = 32.5 (±0.04) µM for LDH assay at 72 hours]. In the trypan blue dye exclusion assay, the Viability Indexes were 52 ± 1.73% for HepG2 cells and 62 ± 4.36% for Chang cells at IC₅₀ after 72 hours. Cytotoxicity of goniothalamin was related to inhibition of DNA synthesis, as revealed by the reduction of BrdU incorporation. At 72 hours, the lowest concentration of goniothalamin (2.3 µL) retained 97.6% of normal liver Chang cells proliferation while it reduced HepG2 cell proliferation to 19.8% as compared to control. Besides, goniothalamin caused accumulation of hypodiploid apoptosis and different degree of G2/M arrested as shown in cell cycle analysis by flow cytometry. Goniothalamin selectively killed liver cancer cell through suppression of proliferation and induction of apoptosis. These results suggest that goniothalamin shows potential cytotoxicity against hepatoblastoma HepG2 cells.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D011753 Pyrones Keto-pyrans.
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D018197 Hepatoblastoma A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed) Hepatoblastomas
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
March 2017, Scientific reports,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
January 2013, Drug delivery,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
January 2013, Natural product research,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
January 2015, PloS one,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
January 2009, Naunyn-Schmiedeberg's archives of pharmacology,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
January 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
August 1994, Metabolism: clinical and experimental,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
January 2010, Archives of pharmacal research,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
October 1995, The Journal of antibiotics,
Mothanna Al-Qubaisi, and Rosli Rozita, and Swee-Keong Yeap, and Abdul-Rahman Omar, and Abdul-Manaf Ali, and Noorjahan B Alitheen
March 2012, Toxicology letters,
Copied contents to your clipboard!